Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anton Gueth currently holds 467,577 shares of ANTARES PHARMA, INC. (ATRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anton Gueth has been a net seller of ATRS stock. They have purchased $57.9K and sold $1.1M worth of shares.
Anton Gueth's most recent insider trade was on May 24, 2022, when they sold 1,800 shares at $5.60 per share.
Anton Gueth serves as Executive at ANTARES PHARMA, INC. (ATRS). They have executed 62 insider transactions totaling $1.2M over their tenure at the company.
Anton Gueth holds the position of Executive at ANTARES PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Anton Gueth has shown a selling trading pattern, with $57.9K in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Anton Gueth was on May 24, 2022, when they sold $2.2M worth of ATRS shares. This transaction involved 386,132 shares at $5.60 per share.
Anton Gueth currently owns 467,577 shares of ANTARES PHARMA, INC. (ATRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anton Gueth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anton Gueth has 62 Form 4 filings on record as an insider at ANTARES PHARMA, INC..
Set alerts for Anton Gueth and 40,000+ other insiders.